Mobile Health Intervention to Increase Oral Cancer Therapy Adherence in Patients With Chronic Myeloid Leukemia (The REMIND System): Clinical Feasibility and Acceptability Assessment

BACKGROUND: Optimal dosing of oral tyrosine kinase inhibitor therapy is critical to treatment success and survival of patients with chronic myeloid leukemia (CML). Drug intolerance secondary to toxicities and nonadherence are significant factors in treatment failure. OBJECTIVE: The objective of this...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :JMIR Mhealth Uhealth
Главные авторы: Pereira-Salgado, Amanda, Westwood, Jennifer A, Russell, Lahiru, Ugalde, Anna, Ortlepp, Bronwen, Seymour, John F, Butow, Phyllis, Cavedon, Lawrence, Ong, Kevin, Aranda, Sanchia, Breen, Sibilah, Kirsa, Suzanne, Dunlevie, Andrew, Schofield, Penelope
Формат: Artigo
Язык:Inglês
Опубликовано: JMIR Publications 2017
Предметы:
Original Paper
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC5738545/
https://ncbi.nlm.nih.gov/pubmed/29212628
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2196/mhealth.8349
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы